Back
Salesforce Vs. PTC Therapeutics Industry Stock Comparison
Buy
74
CRM
Salesforce
Last Price:
354.86
Seasonality Move:
7.78%
Sell
43
PTCT
PTC Therapeutics
Last Price:
49.66
Seasonality Move:
12.24%
Buy
74
Salesforce (CRM)
is a Buy
Is Salesforce a Buy, Sell or Hold?
- The current Salesforce [CRM] share price is $348.82. The Score for CRM is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
- CRM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
PTC Therapeutics (PTCT)
is a Sell
Is PTC Therapeutics a Buy, Sell or Hold?
- The current PTC Therapeutics [PTCT] share price is $49.99. The Score for PTCT is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- PTCT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CRM Stock Price Chart
What is Salesforce's stock price today?
-
The Salesforce share price today is $348.82
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRM is experiencing selling pressure, which indicates risk of future bearish movement.
PTCT Stock Price Chart
What is PTC Therapeutics's stock price today?
-
The PTC Therapeutics share price today is $49.99
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTCT is experiencing selling pressure, which indicates risk of future bearish movement.
CRM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 12.52 | Buy |
| Relative Strength Index (14 RSI): | 60.18 | Buy |
| Chaikin Money Flow: | -3892372 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (318.14 - 351) | Buy |
| Bollinger Bands (100): | (249.94 - 317.78) | Buy |
PTCT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.29 | Buy |
| Relative Strength Index (14 RSI): | 63.91 | Buy |
| Chaikin Money Flow: | -431161 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (41.19 - 48.23) | Buy |
| Bollinger Bands (100): | (32.62 - 42.9) | Buy |
CRM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 348.01 | Buy |
| 20-day SMA: | 339.27 | Buy |
| 50-day SMA: | 311.55 | Buy |
| 200-day SMA: | 279.29 | Buy |
| 8-day EMA: | 349.22 | Sell |
| 20-day EMA: | 338.15 | Buy |
| 50-day EMA: | 316.02 | Buy |
| 200-day EMA: | 279.41 | Buy |
PTCT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.82 | Buy |
| 20-day SMA: | 45.08 | Buy |
| 50-day SMA: | 41.81 | Buy |
| 200-day SMA: | 34.76 | Buy |
| 8-day EMA: | 48.24 | Buy |
| 20-day EMA: | 45.96 | Buy |
| 50-day EMA: | 42.51 | Buy |
| 200-day EMA: | 36.46 | Buy |
Salesforce Earnings Growth & CRM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.34 per share, an increase next quarter of $0.23 per share, an increase this year of $3.27 per share, and an increase next year of $1.84 per share.
PTC Therapeutics Earnings Growth & PTCT Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.03 per share, and an increase next year of $1.04 per share.
Salesforce Technical Analysis
| Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 26 | 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
PTC Therapeutics Technical Analysis
| Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 26 | 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||